133 related articles for article (PubMed ID: 35731178)
1. Differentiation of hemangioblastoma from brain metastasis using MR amide proton transfer imaging.
Kamimura K; Nakajo M; Gohara M; Kawaji K; Bohara M; Fukukura Y; Uchida H; Tabata K; Iwanaga T; Akamine Y; Keupp J; Fukami T; Yoshiura T
J Neuroimaging; 2022 Sep; 32(5):920-929. PubMed ID: 35731178
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of Hemangioblastoma from Metastatic Brain Tumor using Dynamic Contrast-enhanced MR Imaging.
Cha J; Kim ST; Nam DH; Kong DS; Kim HJ; Kim YK; Kim HY; Park GM; Jeon P; Kim KH; Byun HS
Clin Neuroradiol; 2017 Sep; 27(3):329-334. PubMed ID: 26952018
[TBL] [Abstract][Full Text] [Related]
3. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
4. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
[TBL] [Abstract][Full Text] [Related]
5. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
[TBL] [Abstract][Full Text] [Related]
6. Advantage of High b Value Diffusion-Weighted Imaging for Differentiation of Hemangioblastoma from Brain Metastases in Posterior Fossa.
Onishi S; Hirose T; Takayasu T; Nosaka R; Kolakshyapati M; Saito T; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2017 May; 101():643-650. PubMed ID: 28179177
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
Li L; Chen W; Yan Z; Feng J; Hu S; Liu B; Liu X
J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
[TBL] [Abstract][Full Text] [Related]
10. Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma.
Park KJ; Kim HS; Park JE; Shim WH; Kim SJ; Smith SA
Eur Radiol; 2016 Dec; 26(12):4390-4403. PubMed ID: 26883333
[TBL] [Abstract][Full Text] [Related]
11. CEST 2022-three-dimensional amide proton transfer (APT) imaging can identify the changes of cerebral cortex in Parkinson's disease.
Tian Y; Li X; Wang X; Su W; Li S; Wang W; Zhang Y; Li C; Chen M
Magn Reson Imaging; 2023 Oct; 102():235-241. PubMed ID: 37356600
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Hemangioblastomas from Brain Metastases Using Diffusion-Weighted Imaging and Dynamic Susceptibility Contrast-Enhanced Perfusion-Weighted MR Imaging.
She D; Yang X; Xing Z; Cao D
AJNR Am J Neuroradiol; 2016 Oct; 37(10):1844-1850. PubMed ID: 27173365
[TBL] [Abstract][Full Text] [Related]
13. Added-value of 3D amide proton transfer MRI in assessing prognostic factors of cervical cancer: a comparative study with multiple model diffusion-weighted imaging.
Li S; Liu J; Zhang Z; Wang W; Lu H; Lin L; Zhang Y; Cheng J
Quant Imaging Med Surg; 2023 Dec; 13(12):8157-8172. PubMed ID: 38106243
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T.
Liu J; Li C; Chen Y; Lv X; Lv Y; Zhou J; Xi S; Dou W; Qian L; Zheng H; Wu Y; Chen Z
J Magn Reson Imaging; 2020 Apr; 51(4):1154-1161. PubMed ID: 31430008
[TBL] [Abstract][Full Text] [Related]
15. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study.
Yang L; Wang L; Tan Y; Dan H; Xian P; Zhang Y; Tan Y; Lin M; Zhang J
Cancer Imaging; 2023 Jan; 23(1):3. PubMed ID: 36611191
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters.
Park YW; Ahn SS; Kim EH; Kang SG; Chang JH; Kim SH; Zhou J; Lee SK
Neuroradiology; 2021 Mar; 63(3):363-372. PubMed ID: 32879995
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of low- and high-grade pediatric gliomas with amide proton transfer imaging: added value beyond quantitative relaxation times.
Zhang H; Yong X; Ma X; Zhao J; Shen Z; Chen X; Tian F; Chen W; Wu D; Zhang Y
Eur Radiol; 2021 Dec; 31(12):9110-9119. PubMed ID: 34047848
[TBL] [Abstract][Full Text] [Related]
18. Comparison Between Amide Proton Transfer Magnetic Resonance Imaging Using 3-Dimensional Acquisition and Diffusion-Weighted Imaging for Characterization of Prostate Cancer: A Preliminary Study.
Kido A; Tamada T; Ueda Y; Takeuchi M; Kanki A; Yamamoto A
J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):178-185. PubMed ID: 36729617
[TBL] [Abstract][Full Text] [Related]
19. MR dynamic-susceptibility-contrast perfusion metrics in the presurgical discrimination of adult solitary intra-axial cerebellar tumors.
Pons-Escoda A; Garcia-Ruiz A; Garcia-Hidalgo C; Gil-Solsona R; Naval-Baudin P; Martin-Noguerol T; Fernandez-Coello A; Flores-Casaperalta S; Fernandez-Viñas M; Gago-Ferrero P; Oleaga L; Perez-Lopez R; Majos C
Eur Radiol; 2023 Dec; 33(12):9120-9129. PubMed ID: 37439938
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of amide proton transfer imaging for bladder cancer histopathologic features: A comparative study with diffusion- weighted imaging.
Wang F; Xiang YS; Wu P; Shen AJ; Wang PJ
Eur J Radiol; 2023 Feb; 159():110664. PubMed ID: 36574743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
